The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABIVAX SA | SPONSORED ADS | 00370M103 | 765,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
| ADAGIO MED HLDGS INC | COM | 00534B100 | 108,000 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| AKEBIA THERAPEUTICS INC | COM | 00972D105 | 7,098,000 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | |||
| ALKERMES PLC | SHS | G01767105 | 28,610,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
| ALTIMMUNE INC | COM NEW | 02155H200 | 774,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
| AMGEN INC | COM | 031162100 | 11,168,400 | 40,000 | SH | Call | SOLE | 40,000 | 0 | 0 | ||
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | 1,610,750 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 30,049,174 | 691,899 | SH | SOLE | 691,899 | 0 | 0 | |||
| APOGEE THERAPEUTICS INC | COM | 03770N101 | 108,575 | 2,500 | SH | Put | SOLE | 2,500 | 0 | 0 | ||
| ARBUTUS BIOPHARMA CORP | COM | 03879J100 | 28,737 | 9,300 | SH | Call | SOLE | 9,300 | 0 | 0 | ||
| ARCELLX INC | COMMON STOCK | 03940C100 | 32,595,750 | 495,000 | SH | SOLE | 495,000 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 1,608,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
| AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 6,942,600 | 3,045,000 | SH | SOLE | 3,045,000 | 0 | 0 | |||
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 3,033,281 | 607,872 | SH | SOLE | 607,872 | 0 | 0 | |||
| AXSOME THERAPEUTICS INC | COM | 05464T104 | 5,219,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 32,045,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| BRIDGEBIO PHARMA INC | COM | 10806X102 | 6,477,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
| CAPRICOR THERAPEUTICS INC | COM NEW | 14070B309 | 1,737,750 | 175,000 | SH | Put | SOLE | 175,000 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 11,828,129 | 900,162 | SH | SOLE | 900,162 | 0 | 0 | |||
| CLIMB BIO INC | COM | 28658R106 | 1,860,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | 339,410 | 518,025 | SH | SOLE | 518,025 | 0 | 0 | |||
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | 4,519,700 | 280,031 | SH | SOLE | 280,031 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 4,378,768 | 152,252 | SH | SOLE | 152,252 | 0 | 0 | |||
| CRISPR Therapeutics AG | COM | H17182108 | 9,728,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 1,986,542 | 263,817 | SH | SOLE | 263,817 | 0 | 0 | |||
| ENGENE HOLDINGS INC | COM | 29286M105 | 280,280 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 8,024,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| ERASCA INC | COM | 29479A108 | 5,188,949 | 4,085,787 | SH | SOLE | 4,085,787 | 0 | 0 | |||
| ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 14,301,999 | 334,863 | SH | SOLE | 334,863 | 0 | 0 | |||
| EXELIXIS INC | COM | 30161Q104 | 19,833,750 | 450,000 | SH | Put | SOLE | 450,000 | 0 | 0 | ||
| EXELIXIS INC | COM | 30161Q104 | 6,611,250 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | ||
| GALECTIN THERAPEUTICS INC | COM NEW | 363225202 | 527,500 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 2,115,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
| IMMATICS N.V | *W EXP 07/01/202 | N44445117 | 112 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | |||
| INMUNE BIO INC | COM | 45782T105 | 817,740 | 354,000 | SH | Put | SOLE | 354,000 | 0 | 0 | ||
| INOZYME PHARMA INC | COM | 45790W108 | 6,997,436 | 1,749,359 | SH | SOLE | 1,749,359 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 47,804,000 | 475,000 | SH | SOLE | 475,000 | 0 | 0 | |||
| JADE BIOSCIENCES INC | COM NEW | 008064206 | 652,517 | 65,317 | SH | SOLE | 65,317 | 0 | 0 | |||
| JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | 2,653,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | 678,825 | 157,500 | SH | Call | SOLE | 157,500 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 11,620,480 | 15,250,000 | PRN | SOLE | 15,250,000 | 0 | 0 | |||
| LEXEO THERAPEUTICS INC | COM | 52886X107 | 14,429,207 | 3,589,355 | SH | SOLE | 3,589,355 | 0 | 0 | |||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 24,211,200 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
| MERUS N V | COM | N5749R100 | 3,682,000 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
| MINERALYS THERAPEUTICS INC | COM | 603170101 | 12,177,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,256,576 | 24,692 | SH | SOLE | 24,692 | 0 | 0 | |||
| MONOPAR THERAPEUTICS INC | COM NEW | 61023L207 | 2,415,150 | 67,500 | SH | SOLE | 67,500 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 4,980,250 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | *W EXP 99/99/999 | N62509117 | 1,960,000 | 245,000 | SH | SOLE | 245,000 | 0 | 0 | |||
| NEXTCURE INC | COM | 65343E108 | 1,059,195 | 2,302,598 | SH | SOLE | 2,302,598 | 0 | 0 | |||
| NKARTA INC | COM | 65487U108 | 1,328,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
| NOVAVAX INC | COM NEW | 670002401 | 1,575,000 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 11,021,192 | 967,620 | SH | SOLE | 967,620 | 0 | 0 | |||
| NUVALENT INC | COM | 670703107 | 31,664,500 | 415,000 | SH | SOLE | 415,000 | 0 | 0 | |||
| OAKTREE ACQUISITION CORP III | UNIT 10/04/2029 | G6717R120 | 2,655,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 1,065,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| OMEROS CORP | COM | 682143102 | 942,000 | 314,000 | SH | Put | SOLE | 314,000 | 0 | 0 | ||
| OMEROS CORP | NOTE 9.500% 6/1 | 682143AK8 | 7,068,530 | 9,025,000 | PRN | SOLE | 9,025,000 | 0 | 0 | |||
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | 831,696 | 347,990 | SH | SOLE | 347,990 | 0 | 0 | |||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 6,765,000 | 603,479 | SH | SOLE | 603,479 | 0 | 0 | |||
| OVID THERAPEUTICS INC | COM | 690469101 | 220,214 | 667,516 | SH | SOLE | 667,516 | 0 | 0 | |||
| PERCEPTIVE CAP SOLUTIONS COR | CL A ORD SHS | G70077105 | 3,713,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 3,612,000 | 1,050,000 | SH | SOLE | 1,050,000 | 0 | 0 | |||
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 7,139,004 | 3,499,512 | SH | SOLE | 3,499,512 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 24,318,800 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | |||
| Q32 BIO INC | COM | 746964105 | 41,388 | 27,777 | SH | SOLE | 27,777 | 0 | 0 | |||
| RADIOPHARM THERANOSTICS LTD | SPONSORED ADS | 75041J101 | 166,059 | 35,635 | SH | SOLE | 35,635 | 0 | 0 | |||
| RAPPORT THERAPEUTICS INC | COM | 75383L102 | 2,269,941 | 199,643 | SH | SOLE | 199,643 | 0 | 0 | |||
| REPARE THERAPEUTICS INC | COM | 760273102 | 278,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 9,812,000 | 2,200,000 | SH | SOLE | 2,200,000 | 0 | 0 | |||
| ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | 2,160 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 4,508,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
| SAVARA INC | COM | 805111101 | 1,140,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 9,081,970 | 606,678 | SH | SOLE | 606,678 | 0 | 0 | |||
| SUTRO BIOPHARMA INC | COM | 869367102 | 537,368 | 752,722 | SH | SOLE | 752,722 | 0 | 0 | |||
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 462,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | |||
| TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 23,464,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | |||
| THIRD HARMONIC BIO INC | COM | 88427A107 | 2,009,100 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | COM | 89422G107 | 14,356,000 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | |||
| TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 6,685,149 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 13,861,297 | 2,534,058 | SH | SOLE | 2,534,058 | 0 | 0 | |||
| UNIQURE NV | SHS | N90064101 | 1,881,900 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
| UNIQURE NV | SHS | N90064101 | 1,394,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | ||
| VAXCYTE INC | COM | 92243G108 | 4,063,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 9,707,429 | 4,536,182 | SH | SOLE | 4,536,182 | 0 | 0 | |||
| VERA THERAPEUTICS INC | CL A | 92337R101 | 12,840,200 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | |||
| VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 57,693,800 | 610,000 | SH | SOLE | 610,000 | 0 | 0 | |||
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 5,452,200 | 390,000 | SH | SOLE | 390,000 | 0 | 0 | |||
| WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 13,002,002 | 2,000,308 | SH | SOLE | 2,000,308 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 34,430,000 | 1,100,000 | SH | SOLE | 1,100,000 | 0 | 0 | |||
| ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 234,502 | 223,335 | SH | SOLE | 223,335 | 0 | 0 | |||